Aarti Drugs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	88.1	75.61	94.32	89.6	223.3
Short-Term Investments	154.7	145.82	108.89	113.3	120.51
Cash & Short-Term Investments	242.8	221.43	203.2	202.89	343.81
Cash Growth	9.65%	8.97%	0.15%	-40.99%	56.39%
Accounts Receivable	8,299	7,512	7,046	8,648	7,499
Other Receivables	-	188.21	47.17	39.11	6.98
Receivables	8,306	7,708	7,095	8,691	7,506
Inventory	4,908	4,729	4,859	5,163	5,259
Other Current Assets	1,221	725.3	1,050	861.42	824.5
Total Current Assets	14,678	13,384	13,207	14,918	13,934
Property, Plant & Equipment	12,838	11,331	10,351	8,622	7,665
Long-Term Investments	273.1	224.13	199.74	187.99	194.8
Other Intangible Assets	164.3	631.88	368.24	243.34	1.53
Other Long-Term Assets	199.7	176.19	197.04	242.33	284.36
Total Assets	28,153	25,747	24,324	24,214	22,080
Accounts Payable	4,779	4,339	4,496	4,925	4,687
Accrued Expenses	-	85.95	71.78	91.65	76.77
Short-Term Debt	-	-	-	3,605	3,563
Current Portion of Long-Term Debt	3,180	3,282	2,871	412.96	435
Current Portion of Leases	9.5	11.78	9.5	19.92	25.97
Current Income Taxes Payable	-	-	11.81	42.33	-
Other Current Liabilities	1,255	650.14	495.39	397.13	612.7
Total Current Liabilities	9,223	8,370	7,955	9,495	9,401
Long-Term Debt	2,569	2,840	2,753	2,047	1,385
Long-Term Leases	8.6	16.51	9.14	4.03	18.79
Long-Term Unearned Revenue	-	1.6	1.7	1.7	1.7
Pension & Post-Retirement Benefits	-	43.25	27.41	30.35	28.75
Long-Term Deferred Tax Liabilities	812.7	782.33	757.07	709.68	724.31
Other Long-Term Liabilities	47.75	-	-0	-	157.45
Total Liabilities	12,660	12,053	11,504	12,287	11,717
Common Stock	912.7	912.7	919.35	926	926
Retained Earnings	-	12,560	11,701	10,811	9,240
Comprehensive Income & Other	14,576	217.31	194.75	187.48	197.4
Total Common Equity	15,489	13,690	12,815	11,924	10,364
Minority Interest	3.65	3.44	4.06	2.33	-0.6
Shareholders' Equity	15,492	13,693	12,820	11,927	10,363
Total Liabilities & Equity	28,153	25,747	24,324	24,214	22,080
Total Debt	5,766	6,151	5,643	6,089	5,428
Net Cash (Debt)	-5,524	-5,929	-5,440	-5,886	-5,084
Net Cash Per Share	-60.53	-64.96	-59.17	-63.57	-54.91
Filing Date Shares Outstanding	91.22	91.27	91.94	92.6	92.6
Total Common Shares Outstanding	91.22	91.27	91.94	92.6	92.6
Working Capital	5,455	5,014	5,252	5,423	4,533
Book Value Per Share	169.79	149.99	139.40	128.77	111.92
Tangible Book Value	15,324	13,058	12,447	11,681	10,362
Tangible Book Value Per Share	167.99	143.07	135.39	126.14	111.90
Land	-	948.11	937.67	937.67	934.6
Buildings	-	2,419	2,257	1,932	1,921
Machinery	-	11,463	10,633	9,122	8,792
Construction In Progress	-	2,741	2,252	1,868	767.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.